Background
==========

Blindness results mainly from age-related cataract formation \[[@b1-medscimonit-26-e922519]\]. The cataract formation is further influenced by environmental factors and genetic alterations \[[@b2-medscimonit-26-e922519]\]. The presently employed strategy against cataract disease involves the surgical removal of the layer of cataract from the anterior part of the eye \[[@b3-medscimonit-26-e922519]\]. Molecular etiology of cataractogenesis has not been fully elucidated. However, a recent study has shown that apoptosis of epithelial cells of the human lens is responsible for the development of an opaque layer on the eye lens (cataract) \[[@b4-medscimonit-26-e922519]\]. The accumulation of reactive oxygen species (ROS) in the epithelial cells of human lens has been shown to act as a trigger for apoptotic cell death of epithelial cells \[[@b5-medscimonit-26-e922519]\]. Hence, studies are being directed to identify the agents with anti-oxidant properties which may prove helpful in preventing the induction of apoptotic cell death and thus reduce the chances of cataract formation. The present study was therefore undertaken with the purpose to explore the effects of a natural flavonoglycoside, myricetin, in preventing the apoptosis of human eye lens epithelial cells. The rationale for using myricetin in this study was that the flavonoid bear tremendous anti-oxidant potential and have been shown to act as a scavenger of ROS molecules \[[@b6-medscimonit-26-e922519]\]. The anti-oxidant and anti-apoptotic role of myricetin has already been proven in previous studies \[[@b7-medscimonit-26-e922519],[@b8-medscimonit-26-e922519]\]. In the present study, the administration different concentrations of myricetin to human lens epithelial cells resulted in a significant level of decline of ROS entities and inhibited the apoptosis of epithelial cells. Myricetin treatment was shown to enhance the anti-oxidant power of epithelial cells by increasing the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH). The inhibition of apoptosis was mediated through the Bax/Bcl-2 signaling pathway. Taken together, the study highlights the protective role of myricetin to inhibit the apoptosis of human eye lens epithelial cells and thus implicates its effectiveness in preventing the cataract formation on the eye lens.

Material and Methods
====================

Cell culture
------------

The human eye lens epithelial cells (HLEB-3) were bought from the American Type Collection Center (ATCC, USA). The culturing of HLEB-3 cells was performed using the Dulbecco's modified Eagle's medium (DMEM, Thermo scientific). For maintaining the HLEB-3 cells, the cells were incubated using 5% CO~2~ concentration at 37°C in a humidified CO~2~ incubator. The DMEM medium was supplemented with 10% fetal bovine serum (FBS, Thermo Scientific).

Induction of oxidative stress
-----------------------------

For the induction of oxidative stress in HLEB-3 cells, the cells were administered with H~2~O~2~. The H~2~O~2~ was added at the final concentration of 425 μM in the liquid DMEM medium and the cell suspension was incubated at 37°C for 24 hours with 5% CO~2~.

Assessment of ROS levels and anti-oxidant power of epithelial lens cells
------------------------------------------------------------------------

To monitor the production of intracellular level of ROS molecules, the microplate-based ROS estimation was performed using the 525 nm as emission wavelength and 495 nm as excitation wavelength. Prior to determination of intracellular levels of SOD and CAT activities and GSH level, the cells were harvested with centrifugation, washed with phosphate-buffered saline (PBS) thrice and lysed by ultrasonication. The activities of SOD, CAT, and GSH levels were then estimated with the help of respective detection kits.

Analysis of apoptosis
---------------------

To investigate the apoptosis of HLEB-3 cells, the cell cultures were centrifuged, and the pellets were washed thoroughly with PBS buffer. Afterwards, the fixation of cells was done using 70% ethyl alcohol. Subsequently, the HLEB-3 cells were stained using DAPI solution (Thermo Scientific) or dual AO/EB. Lastly, the DAPI or AO/EB stained cells were visualized under the fluorescent microscope to examine the level of apoptosis of HLEB-3 epithelial lens cells. Annexin V/propidium iodide (PI) assay was used as described previously \[[@b7-medscimonit-26-e922519]\] to determine the levels of apoptosis.

Western blotting
----------------

For extracting the total proteins from the HLEB-3 epithelial eye lens cells, the radioimmunoprecipitation assay (RIPA) buffer was used for cell fractionation. The lysed cells were analyzed by Bradford method for examining the total protein concentration. Exactly, 40 μg of proteins were separated by running on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were blotted to PVDF (polyvinylidene fluoride) nylon membrane. Using the exposure of primary and secondary antibodies, the protein bands of proteins of interest were visualized through chemiluminescence method. Human β-actin was used as internal control.

Statistical analysis
--------------------

To validate the experimental findings, the values were depicted as mean±standard deviation (SD). The Student's *t*-test and ANOVA were performed with the help of GraphPad Prism 7.0 statistical analysis software, offline, and the *P*\<0.05 were used as the measure of statistically significant difference.

Results
=======

Myricetin inhibited the accretion of ROS levels in lens epithelial cells
------------------------------------------------------------------------

To produce the oxidative stress in the HLEB-3 epithelial eye lens cells, the cell cultures were inoculated with H~2~O~2~ at a final concentration of 425 μM. The cell cultures were then administered with myricetin, whose molecular structure is presented in [Figure 1](#f1-medscimonit-26-e922519){ref-type="fig"}, to infer whether myricetin treatment is effective in reducing the ROS levels by enhancing the intracellular anti-oxidant parameters like SOD, CAT, and GSH. Myricetin was used in the concentrations of 0, 5, 10, and 20 μM. The results showed that the myricetin administration was effective in reducing the intracellular ROS levels ([Figure 2A](#f2-medscimonit-26-e922519){ref-type="fig"}). The administration further enhanced the intracellular level of SOD enzyme ([Figure 2B](#f2-medscimonit-26-e922519){ref-type="fig"}). Similarly, the intracellular counts of CAT and GSH were also seen to be enhanced when the HLEB-3 cells were treated myricetin ([Figure 2C, 2D](#f2-medscimonit-26-e922519){ref-type="fig"}). The effects of myricetin in reducing the intracellular ROS levels and enhancing the antioxidant parameters of HLEB-3 cells were more prominent at the higher concentrations used. The western blot analysis also showed that the expression of SOD, CAT, and GSH increased dose dependently upon myricetin treatment ([Figure 3](#f3-medscimonit-26-e922519){ref-type="fig"}).

Myricetin inhibited the apoptosis of H~2~O~2~ stressed lens epithelial cells
----------------------------------------------------------------------------

To investigate the effects of myricetin on the apoptosis of HLEB-3 epithelial cells stressed with H~2~O~2~, the oxidative stress inducted cells were treated with 0, 5, 10, or 20 μM for 24 hours of myricetin and the cells were processed for DAPI or AO/EB staining. The results showed that myricetin treatment reduced the apoptosis of HLEB-3 cells in a dose-dependent manner as evident from the DAPI ([Figure 4](#f4-medscimonit-26-e922519){ref-type="fig"}) and AO/EB staining assays ([Figure 5](#f5-medscimonit-26-e922519){ref-type="fig"}). It can be then stated that myricetin, through its ant-apoptotic potential, is effective in prevention of apoptosis driven cataractogenesis of the human eye lens. The Annexin V/PI assay showed that the percent apoptosis decreased from 19.8% in untreated HLEB-3 cells to 7.5% in HLEB-3 cells treated with 20 μM dosage of myricetin ([Figure 6](#f6-medscimonit-26-e922519){ref-type="fig"}).

Myricetin decreased the Bax/Bcl-2 ratio in HLEB-3 cells
-------------------------------------------------------

The western blotting of Bax and Bcl-2 proteins from the HLEB-3 cells stressed with H~2~O~2~ and administered with 0, 5, 10, or 20 μM myricetin was performed to determine the concentrations of Bax and Bcl-2 proteins. The results showed that Bax protein concentration decreased while as that of Bcl-2 increased in myricetin concentration dependent fashion ([Figure 7](#f7-medscimonit-26-e922519){ref-type="fig"}). The results suggest that the myricetin prevents the apoptosis of human epithelial lens cells by modulating the Bax/Bcl-2 protein concentration ratio.

Discussion
==========

The formation of cataract on the human eye lens is the dominant cause of human blindness \[[@b9-medscimonit-26-e922519]\]. The chances of cataract formation particularly increases in the elder age group \[[@b10-medscimonit-26-e922519]\]. Environmental factors together with genetic alterations have been shown to play a role in the cataractogenesis of the human eye \[[@b11-medscimonit-26-e922519],[@b12-medscimonit-26-e922519]\]. Furthermore, the apoptosis of human epithelial lens cells has been implicated as responsible for the development of their opaqueness which is ultimately manifested as the layer of cataract \[[@b13-medscimonit-26-e922519]\]. Oxidative stress is very detrimental to normal cell functioning and reactive oxygen species (ROS), when accumulated, leads to the induction apoptosis of human cells \[[@b14-medscimonit-26-e922519]\]. The natural occurring compounds have the potential to enhance the oxidant potential of human cells and enhance their survival by inhibiting the cell apoptosis \[[@b15-medscimonit-26-e922519]\]. Myricetin, a flavonoglycoside, is isolated from the stem, bark, branches, and fruits of Myrica rubra or other plant sources. Research studies have shown that myricetin has the potential to inhibit the induction of apoptosis of human cells \[[@b16-medscimonit-26-e922519]\]. In this study, we investigated the effects of myricetin on the apoptosis of human lens epithelial cells, HLEB-3. In confirmation with previous reports, the myricetin treatment resulted into the inhibition of apoptosis of HLEB-3 epithelial cells. The reduction of apoptosis of HLEB-3 epithelial cells was attributed to the potential of myricetin to decline the intracellular ROS levels and enhancement of CAT, SOD, and GSH activities. Researchers have reported similar types of effect of myricetin on the human cells in previous reports \[[@b16-medscimonit-26-e922519]\]. Moreover, the myricetin administration led to the inhibition of Bax/Bcl-2 apoptotic signal by increasing the concentration of Bcl-2 and decreasing the Bax protein. This leads to decrease of Bax/Bcl-2 protein ratio which inhibits cell apoptosis \[[@b17-medscimonit-26-e922519]\]. Summing up, myricetin was shown to inhibit the accumulation of ROS molecules in HLEB-3 cells. The inhibition of HLEB-3 cell apoptosis provides insights into the potential of myricetin to prevent the cataract formation through the reduction of the apoptosis driven cataractogenesis of epithelial eye lens in humans.

Conclusions
===========

The results of the current study reveal the potential of myricetin to inhibit the apoptosis of human eye lens epithelial cells and thus highlights its protective role in inhibiting the apoptosis driven cataractogenesis of human eye.

**Source of support:** Departmental sources

![Molecular structure of myricetin.](medscimonit-26-e922519-g001){#f1-medscimonit-26-e922519}

![Myricetin decreases the intracellular ROS level and increases SOD, CAT, and GSH activity of HLEB-3 cells. (**A**) Relative percentage of intracellular ROS level of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. (**B**) Intracellular SOD activity of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. (**C**) Intracellular CAT activity of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. (**D**) Intracellular GSH level of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. The experiments were performed in triplicate and expressed as mean±standard deviations (SD) (\* *P*\<0.05). ROS -- reactive oxygen species; SOD -- superoxide dismutase; CAT -- catalase; GSH -- glutathione; HLEB-3 -- human eye lens epithelial cells; H~2~O~2~ -- hydrogen peroxide.](medscimonit-26-e922519-g002){#f2-medscimonit-26-e922519}

![Western blot analysis showing the expression of SOD, CAT, and APX in H~2~O~2~ treated HLEB-2 cells. The experiments were performed in triplicate. SOD -- superoxide dismutase; CAT -- catalase; GSH -- glutathione; APX -- ascorbate peroxidase; H~2~O~2~ -- hydrogen peroxide; HLEB-3 -- human eye lens epithelial cells.](medscimonit-26-e922519-g003){#f3-medscimonit-26-e922519}

![Inhibition of apoptosis of HLEB-3 cells by myricetin. DAPI staining for the assessment of apoptosis of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. The experiments were performed in triplicate. DAPI -- 4′,6-diamidino-2-phenylindole; H~2~O~2~ -- hydrogen peroxide.](medscimonit-26-e922519-g004){#f4-medscimonit-26-e922519}

![Myricetin inhibits apoptosis of HLEB-3 cells. AO/EB dual staining for the assessment of apoptosis of H~2~O~2~ stressed HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. The experiments were performed in triplicate. AO/EB -- acridine orange/ethidium bromide; H~2~O~2~ -- hydrogen peroxide.](medscimonit-26-e922519-g005){#f5-medscimonit-26-e922519}

![Annexin V/PI staining showing the percentage of apoptosis at different concentration of myricetin in H~2~O~2,~ treated HLEB-2 cells. The experiments were performed in triplicate. Annexin V/PI -- Annexin V/propidium iodide (PI); H~2~O~2~ -- hydrogen peroxide.](medscimonit-26-e922519-g006){#f6-medscimonit-26-e922519}

![Myricetin modulates the Bax/Bcl-2 ratio to inhibit apoptosis of HLEB-3 cells. Western blotting of Bax and Bcl-2 proteins from HLEB-2 cells treated with 0, 5, 10, or 20 μM myricetin. The experiments were performed in triplicate. The experiments were performed in triplicate.](medscimonit-26-e922519-g007){#f7-medscimonit-26-e922519}
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